Health Care & Life Sciences » Pharmaceuticals | Kwang Dong Pharmaceutical Co. Ltd.

Kwang Dong Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
468,385
522,274
955,454
1,056,429
1,141,566
1,180,220
Cost of Goods Sold (COGS) incl. D&A
299,922
330,271
727,368
808,992
899,860
942,523
Gross Income
168,463
192,004
228,086
247,437
241,706
237,697
SG&A Expense
122,418
141,733
176,327
202,108
204,375
202,637
EBIT
44,347
49,458
50,800
44,164
35,737
32,852
Unusual Expense
3,000
-
130
1,991
2,885
3,298
Non Operating Income/Expense
919
1,744
28
911
1,596
2,859
Interest Expense
2,296
2,196
2,644
2,592
2,459
2,784
Pretax Income
39,827
47,350
49,718
40,193
33,351
31,396
Income Tax
17,828
12,287
13,635
12,293
10,268
9,421
Consolidated Net Income
21,999
35,063
36,083
27,900
23,083
21,974
Net Income
22,037
35,044
35,015
28,063
23,196
22,345
Net Income After Extraordinaries
22,037
35,044
35,015
28,063
23,196
22,345
Net Income Available to Common
22,037
35,044
35,015
28,063
23,196
22,345
EPS (Basic)
538.00
869.00
868.00
692.00
572.00
550.82
Basic Shares Outstanding
41
40
40
41
41
41
EPS (Diluted)
538.08
869.21
867.63
691.53
571.61
550.82
Diluted Shares Outstanding
41
40
40
41
41
41
EBITDA
51,937
57,056
62,324
58,685
51,027
50,263
Other Operating Expense
1,697
813
960
1,165
1,593
2,208
Non-Operating Interest Income
1,694
1,832
1,404
1,523
1,361
1,781
Minority Interest Expense
39
19
1,068
163
113
371

About Kwang Dong Pharmaceutical Co.

View Profile
Address
85 Seochojungang-ro
Seoul SL 06650
Korea, Republic Of
Employees -
Website http://www.ekdp.com
Updated 07/08/2019
Kwang Dong Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Pharmacy Sales, Hospital Sales, Distribution Sales, Water Sales and Others. The Pharmacy Sales division provides medicines for cold, high blood pressure and cerebral apoplexy.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.